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Abstract: There is a signiﬁcant need for antibodies that can bind targets with greater
aﬃnity. Here we describe a novel strategy employing chemical semisynthesis to produce
symmetroadhesins: antibody-like molecules having nonprotein hinge regions that are more ﬂexible
and extendible and are capable of two-handed binding. Native chemical ligation was carried out
under mild, non-denaturing conditions to join a ligand binding domain (AO peptide) to an IgG1 Fc
dimer via discrete oxyethylene oligomers of various lengths. Two-handed AO–Fc fusion proteins
were obtained in quantitative yield and shown by surface plasmon resonance to bind an anti-AO
antibody with a KD at least two orders of magnitude greater than the cognate AO peptide. MALDI-
TOF MS analysis conﬁrmed the protein/nonprotein/protein structure of the two-handed molecules,
demonstrating its power to characterize complex protein-nonprotein hybrids by virtue of
desorption/ionization mediated by peptide sequences contained therein. We anticipate many
applications for symmetroadhesins that combine the target speciﬁcity of antibodies with the novel
physical, chemical and biological properties of nonprotein hinges.
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Introduction
The essence of the antibody molecule is its Y-
shape. By 1940, Pauling1) had envisioned that
antibodies have three regions and correctly predicted
that the middle part has the same conﬁguration as
normal .-globulin while the two ends have variable
conﬁgurations that are complementary to the surface
of the antigen. Porter2) proved in 1958 that .-
globulin is formed from three globular sections,
demonstrating that they could be split apart by
papain. The sequence of one of these parts (Fc) was
shown to be essentially conserved in all .-globulins,
while the other two parts (Fab) varied considerably
in sequence from molecule to molecule. By 1969,
Edelman and colleagues3) presented a complete
description of the connections between the Fab and
Fc regions. Papain cleavage occurs within the two
heavy chains releasing the Fab arms, each a light
chain attached to the N-terminal portion of a heavy
chain by a disulﬁde, from the Fc fragment, a
disulﬁde-linked dimer of the C-terminal half of the
heavy chains. All of the cysteines participating in
these interchain disulﬁdes bonds are clustered at the
center of the heavy chain, giving the .-globulins their
Y-shape.
A more dynamic picture of .-globulin structure
has emerged from electron microscopy of antibody-
antigen complexes.4),5) In the presence of divalent
haptens, antibodies form cyclic dimers, trimers,
tetramers, pentamers and larger structures.
Although the Fab and Fc parts have the appearance
of rigid rods, the angle between them varies from zero
to 180°, allowing them to bridge antigens at distances
up to 120Å. The antibody behaves as if all three
parts were joined by a “hinge”, the name now used for
the heavy chain region containing the interchain
disulﬁdes. Despite its small size, just ten amino acids
in IgG1, the hinge displays considerable variation in
its conﬁguration. The one available crystal structure
of a human IgG1 with a full-length hinge6) reveals
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©2011 The Japan Academyextreme asymmetry in the placement of the Fab
arms, reﬂecting diﬀerences in their distance and
rotational displacement from the Fc. Although the
hinges on adjacent heavy chains are separated by no
more than 18Å, the Fab arms diverge at a 148° angle
along their major axes and are rotated by 158° along
their depth axes.
Beginning in 1989, Capon and his Genentech
collaborators reported that the Fab arms of IgG
could be replaced with a variety of other proteins7)–14)
including the extracellular domains of CD4, L-
selectin, and tumor necrosis factor (TNF) receptor.
These Y-shaped antibody-like molecules (called
immunoadhesins or Fc fusion proteins) are cleaved
by papain, like antibodies, into three fragments and
have many of the biological properties of IgG
including a long plasma half-life, Fc receptor and
complement binding, and the ability to cross the
placenta. All were shown to have therapeutic
potential: CD4 immunoadhesin prevented HIV-1
infection in the chimpanzee, L-selectin immunoadhe-
sin blocked neutrophil inﬂux in mice, and TNF
receptor immunoadhesin protected mice against
lethal endotoxic shock. Their prolonged half-life in
the blood7) has proven particularly valuable, leading
to the approval of ﬁve therapeutic drugs:15) etaner-
cept (TNF receptor), abatercept (CTLA-4), alefa-
cept (LFA-3), rilonbacept (IL-1 receptor), and
romiplostim (thrombopoietin analog).
Such therapeutic antibodies are directed against
targets that are multimeric proteins, suggesting they
could be improved if both arms could grasp a
particular target molecule. Unfortunately, this task
is not straightforward as the hinge normally points
the Fab arms away from each other. Outwardly
pointing arms may have evolved to grasp large
disease targets such as a bacteria, however inwardly
pointing arms would be more suitable for grasping
smaller targets such as proteins (e.g., TNF). The
latter would likely require that the hinge is not only
ﬂexible, but extendible to a distance of at least
several nanometers away from Fc, a combination of
properties found in many types of polymer chains,
but typically lacking in polypeptides.16)
An attractive solution would be to employ
nonprotein chains to create antibody hinges that
are both ﬂexible and extendible. Here we describe
signiﬁcant progress towards these goals. We devised
a chemical strategy based upon native chemical
ligation17) that gives quantitative yields of Fc fusion
proteins yet is compatible with the native, bio-
logically active Fc molecule. Using this approach we
fused a 15 amino acid stretch representing the
immunodominant epitope of Alzheimer’sA O(1–42)
ﬁbrils18)–21) and successfuly incorporated nonprotein
chains between the AO and Fc moieties. MALDI-
TOF MS, as pioneered by Tanaka and col-
leagues,22),23) was applied to unambiguously solve
the structure of the nonprotein chain by virtue of the
ionization and desorption of the adjacent protein
regions. Our two-handed molecules bind targets with
exceptional aﬃnity, opening a promising avenue for
the future development of improved antibody-based
therapies.
Materials and methods
Human IgG1 Fc protein. The recombinant
Fc protein (called Fc6) was expressed in Chinese
hamster ovary (CHO) cells and puriﬁed by Protein A
aﬃnity chromatography. A DNA expression vector
was designed that directs the expression of a chimeric
protein containing the human sonic hedgehog
homolog (SHH) signal sequence fused to the human
IgG1 heavy chain hinge region beginning at the
226CPPC core hinge sequence (heavy chain residues
are numbered according to the Eu format3); residue
226Cys corresponds to Cys239 in Kabat & Wu
format).24) The sequence of this vector (pCDNA3-
SHH-IgG1-Fc11) is described in Capon, D.J.
(November 20, 2008) World Patent Cooperation
Treaty, Publication No. WO/2008/140477. Follow-
ing secretion and cleavage of the SHH signal
sequence, the resulting mature Fc6 polypeptide has
a predicted length of 222 residues. Production of
Fc6 protein was executed by transient expression in
CHO-DG44 cells, adapted to serum-free suspension
culture. Transient transfections were done with
polyethylenimine as transfection agent, complexed
with DNA, under high density conditions as pre-
viously described.25) Seed train cultures were main-
tained in TubeSpin® bioreactor 50 tubes and scaled
up in volume to generate suﬃcient biomass for
transfection. Transfections were carried out in
cultures of 0.5 Liter to 1 Liter. Cultures at this scale
were maintained in 2 Liter or 5 Liter Schott-bottles
with a ventilated cap. The bottles were shaken at
180rpm in a Kühner incubator shaker with humid-
iﬁcation and CO2 control at 5%. The cell culture ﬂuid
was harvested after 10 days, centrifuged and sterile-
ﬁltered, prior to puriﬁcation. The culture super-
natant was applied to a column packed with rProtein
A Fast Flow (GE Healthcare Bio-Sciences AB,
Uppsala, Sweden) pre-equilibrated with Dulbecco’s
phosphate buﬀered saline without Ca or Mg salts
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CA). The column was washed extensively with PBS
and the Fc6 protein eluted with 0.1M glycine buﬀer
pH 2.7. Fractions were collected into tubes contain-
ing 0.05 v/v 1.0M Tris-HCL pH 9.0 (giving a ﬁnal
pH of 7.5), pooled, dialyzed against PBS, and stored
at 4°C prior to use.
Peptides. All peptides used in this study
(Table 1) were synthesized by an Fmoc/t-Butyl
solid-phase strategy on a 2-chlorotrityl chloride resin
preloaded with the Fmoc-Thr(tBu)-OH. Amino acid
derivatives were obtained from CPC Scientiﬁc
(Sunnyvale, CA), Fmoc-PEGx-OH derivatives were
purchased from Quanta BioDesign (Powell, OH),
and 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyl-
aminium hexaﬂuorophosphate (HBTU), dichloro-
methane (DCM), trichloroacetic acid (TFA), N,N′-
diisopropylcarbodiimide (DIC), 1-hydroxybenzotri-
azole (HOBt), N,N′-diisopropylethylamine (DIEA)
and triisopropylsilane (TIS) were purchased from
Sigma (St. Louis, MO). The standard HBTU
activation was employed for peptide elongation.
Peptides 2–4 required the insertion of a Fmoc-
PEGx-OH (x F 12, 24 and 36, respectively). As a
ﬁnal step in peptide elongation, the terminal ,-Fmoc
(9-ﬂuorenylmethoxycarbonyl) protecting group was
converted to Boc (tert-butoxycarbonyl). The peptide
resin was washed with DCM and cleaved with 1%
TFA/DCM to yield the fully protected peptide
with a free carboxylic acid on the C-terminus. The
thioester of the peptides was formed by treating
the crude protected peptide with DIC/HOBt/DIEA
and either thiophenol (peptides 1, 2, 5) or benzyl
mercaptan (peptides 3, 4) in DCM overnight. After
concentration, the crude protected peptide thioester
was precipitated by multiple triturations with cold
ether followed by centrifugation. Deprotection was
carried out by treatment of the crude protected
product with 95:2.5:2.5 TFA/TIS/H2O for 2 hours at
room temperature. After precipitation with ice-cold
ether the deprotected peptide thioester was puriﬁed
by preparative RP-HPLC in a H2O-acetonitrile
(0.1% TFA) system to aﬀord the ﬁnal product with
91–95% purity and the desired MS.
Chemical semisynthesis of symmetroadhe-
sins. 2-(N-morpholino)ethanesulfonic acid (MES)
was purchased from Acros (Morris Plains, NJ),
tris(2-carboxyethyl)phosphine (TCEP) was pur-
chased from Pierce (Rockford, IL), and 4-mercapto-
phenylacetic acid (MPAA) was purchased from
Sigma-Aldrich (St. Louis, MO). Reactions contained
50mM MES buﬀer pH 6.5, 0.8mM TCEP, 10mM
MPAA, 5mg/ml of the peptide thioester, and
1mg/ml of Fc6 protein. Following incubation for 15
hours at room temperature, reactions were adjusted
to pH 7.0 with 0.05 v/v of 1M Tris-HCl pH 9.0 and
puriﬁed on HiTrap Protein A HP columns purchased
from GE Healthcare (Piscataway, NJ). The reaction
products were analyzed by SDS polyacrylamide gel
electrophoresis (SDS-PAGE) under reducing condi-
tions using NuPAGE® Novex Bis-Tris Midi Gels
(10%) purchased from Invitrogen (Carlsbad, CA).
Proteins were visualized using Silver Stain Plus or
Coomassie Brilliant Blue R-250 purchased from Bio-
Rad (Hercules, CA).
In-gel tryptic digestion of proteins. HPLC-
grade acetonitrile (ACN) and triﬂuoroacetic acid
(TFA) were purchased from Wako Pure Chemical
Industries (Osaka, Japan). Ammonium bicarbonate
(NH4HCO3), dithiotreitol (DTT) and iodoacetamide
(IAA) were purchased from Nacalai Tesque (Kyoto,
Japan). Sequence grade Trypsin was purchased from
Promega (Madison, WI). The protein bands from the
gel were excised and destained with 300µl of 50% v/v
ACN in 50mM NH4HCO3 at 4°C for 45min. The gel
pieces were dehydrated in 150µl of 100% ACN for
Table 1. Synthetic peptides used in this study
Peptide No. Mr (Da) MHD Sequence
AO-DKTHT 1 2515.6 2516.68 DAEFRHDSGYEVHHQ-DKTHT-thioester
AO-PEG12-DKTHT 2 3115.6 3115.64 DAEFRHDSGYEVHHQ-PEG12-DKTHT-thioester
AO-PEG24-DKTHT 3 3629.7 3629.67 DAEFRHDSGYEVHHQ-PEG24-DKTHT-thioester
AO-PEG36-DKTHT 4 4158.2 4158.40 DAEFRHDSGYEVHHQ-PEG36-DKTHT-thioester
DKTHT 5 776.8 776.60 Azidoacetyl-DKTHT-thioester
pen-AO 6 1921.0 1921.94 pentynoyl-DAEFRHDSGYEVHHQ-NH2
AO-pra 7 1905.9 1906.56 DAEFRHDSGYEVHHQ-propargylglycine-NH2
Amino acid sequences are shown in boldface.
Thioester F thiophenol (peptides 1, 4, 5); benzyl mercaptan (peptides 2, 3).
Mr, relative molecular mass; MHD, monoisotypic mass value (observed).
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Speed Vac® for 30min. A volume of 100µl of 10mM
DTT in 50mM NH4HCO3 was added to the dried gels
to reduce sulﬁde bond for 1 hour at 37°C. After the
solution was removed, the proteins were alkylated in
100µl of 55mM IAA in 50mM NH4HCO3 for 1hour
at room temperature under the dark. Afterward
the gel pieces were washed with 150µl of 50mM
NH4HCO3 and then dehydrated in 150µl of 100%
ACN. This step was repeated 2 times. The gel pieces
were then dried in a vacuum centrifuge for 30min.
The dried gels were rehydrated with 2µl of 50ng/µl
Trypsin in 50mM NH4HCO3 and incubated for 5min
at room temperature. Then, 18µl of ultrapure water
was further added and the proteins were digested at
37°C overnight. After digestion, 40µl of 50% v/v
ACN containing 0.1% v/v TFA was added to the
digestion mixtures and the gel pieces were sonicated
for 15min. The supernatant was collected into a new
0.5ml tubes.
MALDI-TOF MS analysis. MALDI mass
spectra were obtained using AXIMA performance
MALDI-TOF mass spectrometer (Shimadzu/
KRATOS, Manchester, UK) equipped with a 337
nm nitrogen laser in the positive ion reﬂectron mode
and linear mode. ,-cyano-4-hydroxy-cinnamic acid
(CHCA) and sinapinic acid (SA) were obtained from
LaserBio Labs (Sophia-Antipolis Cedex, France). As
the MALDI matrices, CHCA was used for trysin-
digested proteins and SA was used for SEC-separated
proteins. The matrix solutions were prepared by
dissolving 5mg of the matrix compounds in 0.5ml of
50% v/v ACN containing 0.1% v/v TFA. The sample
solution (0.5µl) was mixed with an equivalent
amount of the matrix solution on the target plate
and then dried at room temperature for MALDI-
TOF MS analysis. The m/z values were calibrated
with 2pmol each of [Angiotensin I D HD]( m/z
1296.7), [Angiotensin II D HD]( m/z 1046.5),
[[Glu1]-Fibrinopeptide B D HD]( m/z 1570.7), [N-
acetyl-resin substrate tetradecapeptide I D HD]( m/z
1800.9), [ACTH fragment 1–17 D HD]( m/z 2093.1)
and [ACTH fragment 18–39 D HD]( m/z 2464.2), and
3pmol of [ACTH fragment 7–38 D HD]( m/z 3656.9),
7.5pmol of [Bovine serum albumin D HD]( m/z
66430.09 (average)) and [Aldolase D HD]( m/z
39212.28 (average)) as external standard.
Size exclusion chromatography (SEC). SEC
was carried out with similar results using a Prom-
inence HPLC System (Shimadzu Corp, Kyoto,
Japan) or an AKTA Avant FPLC System (GE
Healthcare, Piscataway, NJ). TSKgel columns were
purchased from TOSOH Bioscience (Tokyo, Japan).
Mobile phase, ﬂow rate, column temperature, and
detection wavelength used were 50mM sodium
phosphate pH 7.4 and 300mM NaCl, 0.35mL/min,
25°C, and 214/280nm, respectively. All four AO-
PEGx-Fc symmetroadhesins (x F 0, 12, 24, and 36)
were analysed side-by-side in each experiment. To
analyse the eﬃciency of synthesis of the two-handed
molecules, 5µL of each Protein A puriﬁed reaction
product was applied to a TSKgel SuperSW3000
[4.6mm I.D. # 30cmL] column. The ratio of the
molecular species was calculated from the area under
each peak. To conﬁrm the subunit structures of
the two-handed and one-handed molecules by SDS-
PAGE, the Protein A puriﬁed reaction products were
ﬁrst concentrated 10-fold using an 0.5ml Amicon
Ultracel-3K centrifugal ﬁlters (Millipore, Cork, IR);
50µl of each concentrate was then applied to four
TSKgel columns coupled in series (2 G2000SWXL
and 2 G3000SWXL [7.8mm I.D. # 30cmL] columns).
Fractions were then analyzed using NuPAGE®
Novex Bis-Tris Midi Gels (4–12%) under reducing
conditions. For the determination of the molecular
weight of the two major species observed by SEC,
50µL of each Protein A puriﬁed reaction was applied
to TSKgel G3000SWXL [7.8mm I.D. # 30cmL]
column. Peak fractions were analysed by MALDI-
TOF MS analysis in the linear mode.
Surface plasmon resonance (SPR). SPR
studies were carried out using a Biacore T100
instrument (Biacore AB, Uppsala, Sweden). The
ligand, biotin-labeled 6E10 monoclonal antibody
(Covance, Princeton, NJ), was immobilized at a
concentration of 10mg/ml in PBS onto a CAP sensor
chip, Series S, using a Biotin CAPture Kit (GE
Healthcare, Piscataway, NJ). The sensor chip was
loaded with the streptavidin capture reageant and
regenerated according to the manufacturer’s instruc-
tion, including an additional regeneration step with
0.25M NaOH in 30% acetonitrile. Binding of the AO
symmetroadhesins and AO peptides was carried out
at 25°C in 10mM Hepes buﬀer pH 7.4, 150mM NaCl,
3mM EDTA, and 0.005% Tween-20. Data was
evaluated using Biacore T100 Evaluation Software,
version 2.0.3.
Results
Quantitative synthesis of symmetroadhesins.
Our strategy for chemical semisynthesis of AO
symmetroadhesins is summarized in Fig. 1. Native
chemical ligation was carried out with recombinant
Fc protein (Fc6) engineered to have cysteine residues
D. J. CAPON et al. [Vol. 87, 606Fig. 1. Chemical semisynthesis of AO-PEGx-Fc fusion proteins, showing the following steps: (A) reversible formation of the S-acyl
intermediate by transthioesteriﬁcation; (B) the S-acyl intermediate undergoing spontaneous S- to N-acyl migration; (C) irreversible
formation of the peptide bond via a ﬁve-membered ring intermediate. The sequences of the IgG1 hinge region are shown in boldface.
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non-denaturing conditions that favor a stable Fc
dimer, yet maintain the sulfhydryl groups of the N-
terminal cysteines in a reduced state, allowing the Fc6
molecule to readily react with C-terminal thioesters.
Nucleophilic acyl substitution involving both N-
terminal sulfhydryls of the Fc6 molecule as nucleo-
philes (Fig. 1A) leads to thioester-linked intermedi-
ates with two AO thioesters (Fig. 1B). Subsequent
nucleophilic attack by both of the Fc6 N-terminal
amino groups followed by intramolecular rearrange-
ment results in irreversible peptide bond formation
between Fc6 and two AO peptides (Fig. 1C).
To obtain the Fc6 protein, we employed a
recombinant DNA construct that placed a signal
sequence adjacent to a cysteine residue normally
found in the hinge region. The IgG1 hinge region
contains three cysteine residues: 220Cys in the upper
hinge region (CDKTHT) which usually participates
in the disulﬁde bond between the heavy and light
chains, and 226Cys and 229Cys in the core hinge region
(CPPC) which are sometimes present in the inter-
chain disulﬁde bonds between two heavy chains.
We selected 226Cys over 220Cys as the N-terminus for
our Fc molecules, since molecules with 220Cys at their
N-terminus (Fc3) were less easily reduced as judged
by thiol-sepharose binding experiments (not shown).
In addition, 226Cys was selected over 229Cys as the N-
terminus since it has a greater potential to stabilize
symmetroadhesins, as suggested by crystallographic
structures of human IgG1 showing the 226Cys
residues clearly covalently bonded while the 229Cys
residues are visibly separated.17)
The signal sequence of the sonic hedgehog
homolog (SHH) was chosen for the secretion and
processing of the Fc protein since its own mature
polypeptide has an N-terminal cysteine. The
pCDNA3-SHH-IgG1-Fc11 construct eﬃciently di-
rected the synthesis of the Fc6 protein following
transient transfection of Chinese Hamster Ovary
(CHO) cells. Figure 2 shows that the Fc6 product
obtained by aﬃnity puriﬁcation of the transfected
CHO cell supernatants has an apparent molecular
weight of 27,000 daltons on SDS-PAGE under
reducing conditions (lane 1). The Fc6 protein was
well expressed in transient transfections reaching
levels exceeding 0.8g/L and was found to quantita-
tively bind and elute from Protein A aﬃnity resins.
The ability of Fc6 to react with ﬁve diﬀerent C-
terminal thioesters (listed in Table 1) was inves-
tigated. All ﬁve thioesters contain a portion of the
upper hinge region (DKTHT) at their C-terminus.
Four of the ﬁve thioesters also contained a 15 amino
acid sequence from the human AO protein
(DAEFRHDSGYEVHHQ) joined at its C-terminus
to the N-terminus of the upper hinge region. In
addition, three of the AO containing thioesters
incorporated a nonpeptide chain between the AO
and upper hinge sequences. The nonpeptide portion
in these peptides consisted of discrete oxyethylene
oligomers (PEG) of chain lengths 12, 24, or 36.
Figure 2 shows that Fc6 reacted quantitatively
with all ﬁve thioesters, yielding a ladder of products
of increasing size on SDS-PAGE under reducing
conditions (lanes 2–6). The addition of the PEG12
oligomer gave a size increase on SDS-PAGE similar
to the 15 amino acid residue AO sequence (compare
Fig. 2, lanes 2–4). This suggests that a single amino
acid residue and a single oxyethylene monomer
unit make similar contributions to contour length,
consistent with the comparable lengths of their trans
conformations (approximately 3.5 to 4Å).16) The
addition of PEG24 and PEG36 gave further size
increases over PEG12 that were consistent (compare
Fig. 2, lanes 3–6).
Since we produced Fc6 as a native, folded
protein by secretion in mammalian cells, it was
critically important to avoid the use of chaotropic
agents and strong reducing conditions typically
employed in other native chemical ligation studies.17)
3  2 4  6  5  1 
Fc6 
DKTHT-Fc6 
DAEFRHDSGYEVHHQ-DKTHT-Fc6 
DAEFRHDSGYEVHHQ-PEG12-DKTHT-Fc6 
DAEFRHDSGYEVHHQ-PEG24-DKTHT-Fc6 
DAEFRHDSGYEVHHQ-PEG36-DKTHT-Fc6 
1 
2 
3 
4 
5 
6 
20 - 
40 - 
60 - 
kDa 
Fig. 2. SDS-PAGE analysis of the unreacted Fc6 protein and
chemically synthesized fusion proteins as follows: (1) Fc6; (2)
DKTHT-Fc6; (3) AO-Fc; (4) AO-PEG12-Fc; (5) AO-PEG24-Fc;
(6) AO-PEG36-Fc.
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as the Fc6 protein was found to be essentially
unreactive with thioesters otherwise (not shown).
Quantitative yields of symmetroadhesins (>90%)
were readily obtained as seen in Fig. 2 by combining
a non-thiol reducing agent such as tris(2-carboxy-
ethyl)phosphine with a thiol reducing agent such 4-
mercaptophenylacetic acid.26)
Symmetroadhesin primary structure analy-
sis. To conﬁrm the exact nature of the chemical
linkage between the AO sequence and Fc6, we
analyzed the monomer structures of the four AO
symmetroadhesins by mass spectrometry. The AO-
Fc, AO-PEG12-Fc, AO-PEG24-Fc and AO-PEG36-Fc
symmetroadhesin reaction products were puriﬁed by
SDS-PAGE and characterized using in-gel tryptic
digestion. The peaks detected by MALDI-TOF MS
were ﬁt to the theoretical peptides predicted for each
symmetroadhesin, yielding a sequence coverage
between 78.9–81.8% (Fig. 3A–D). This sequence
coverage was suﬃcient to uniquely identify each of
the symmetroadhesins. We focused our analysis on
two sequences: the AO-PEGx-DK fragment which
should be diﬀerent in all four symmetroadhesins,
and the THT-Fc6 fragment which represents the
chemical ligation site and should be identical in all
four symmetroadhesins (Fig. 3E). The theoretical
m/z values for these ﬁve predicted sequences are
shown in Fig. 3F. The observed MS spectra revealed
peaks at m/z values that are in excellent agreement
with all four unique fragments (AO-DK, AO-
PEG12-DK, AO-PEG24-DK, AO-PEG36-DK) as well
as the common ligation site fragment (THT-
CPPCPAPELLGGPSVFLFPPKPK).
Symmetroadhesin subunit molecular struc-
ture. The AO symmetroadhesin reaction products
were expected to have a dimeric structure similar to
the parent Fc6 molecule. In addition, given the small
amount (<10%) of apparently unreacted material
Fc6 observed in all four reactions (Fig. 2, lanes 3–6),
each reaction product could be a mixture of
homodimers having two AO “hands”, heterodimers
having one AO “hand”, and unreacted Fc6 homo-
dimers. Accordingly, size-exclusion chromatography
(SEC) was used to investigate the subunit molecular
structure of the four AO symmetroadhesins. The AO-
Fc, AO-PEG12-Fc, AO-PEG24-Fc and AO-PEG36-
Fc reaction products were puriﬁed from unreacted
thioester by Protein A aﬃnity chromatography and
then analyzed by SEC under native, non-reducing
conditions (50mM sodium phosphate pH 7.4,
300mM NaCl). Figure 4 shows that all four of the
symmetroadhesin reaction products exhibited two
main peaks. The sizes of these two main peaks
increased in the order AO-Fc < AO-PEG12-Fc < AO-
PEG24-Fc < AO-PEG36-Fc (Fig. 4A–D). Further-
more, the size separation between the two main
peaks that was observed for a given symmetroadhesin
reaction product increased in the same relative order.
In addition, all four symmetroadhesin reaction
products displayed a smaller minor peak at 24.4min
having the size expected for unreacted Fc6 dimer.
Together, these observations suggested that the
larger and smaller major peaks represent the pre-
dicted “two-handed” and “one-handed” symmetroad-
hesins, respectively. As summarized in Table 2, the
two-handed symmetroadhesin candidate was the
major product observed in each of the four reactions
(66–74%). Finally, three of the reaction products also
exhibited a minor higher molecular weight (HMW)
peak (Fig. 4A, C, D). As for the two main peaks,
the size of this peak increased with the length of the
oxyethylene oligomer.
To conﬁrm the predicted subunit structures of
the two-handed and one-handed symmetroadhesins,
preparative SEC was carried out under the native,
non-reducing conditions (Fig. 5A) and the resulting
column fractions were analyzed by SDS-PAGE under
reducing conditions (Fig. 5B–E). In each of the four
symmetroadhesin reactions, the candidate peak for
the two-handed symmetroadhesin consisted almost
exclusively of the expected AO-PEGx-Fc product
(x F 0, 12, 24, 36), conﬁrming its homodimeric
structure. Similarly, the candidate peak for the one-
handed symmetroadhesin consisted of a 1:1 ratio
of the expected AO-PEGx-Fc product and appar-
ently unreacted Fc6, conﬁrming its heterodimeric
structure.
To establish the exact molecular relationship
between the two-handed and one-handed symme-
troadhesins, the two main peaks observed on ana-
lytical size-exclusion chromatograms were analyzed
Table 2. AO-PEGx-Fc symmetroadhesin product ratios deter-
mined by size exclusion chromatograpy (SEC)
Reaction Two-handed One-handed No AO hand HMW
AO-Fc 72.7% 24.6% 2.5% 0.2%
AO-PEG12-Fc 66.1% 29.5% 4.4% ND
AO-PEG24-Fc 74.6% 19.8% 2.8% 2.8%
AO-PEG36-Fc 70.9% 24.1% 2.6% 2.4%
The product ratios for each the four (4) reactions shown in
Fig. 3A–D were calculated directly from the area of each peak.
HMW, higher molecular weight species; ND, not detected.
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m/z value Aβ-PEGx-DK fragment THT-Fc6 fragment
Aβ-Fc 1451.63 2844.46
Aβ-PEG12-Fc 2050.98 2844.46
Aβ-PEG24-Fc 2579.30 2844.46
Aβ-PEG36-Fc 3107.61 2844.46
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Fig. 3. MS spectra of tryptic peptides of the four AO-PEGx-Fc fusion proteins, which are as follows: (A) AO-Fc; (B) AO-PEG12-Fc; (C)
AO-PEG24-Fc; (D) AO-PEG36-Fc. The asterisks (*) denote the peaks from the fusion proteins. The insets show the AO-PEGx-DK and
THT-Fc6 tryptic fragments. (E) Predicted sequence of the ligation site showing the site of trysin cleavage. (F) Theoretical m/z values
of the tryptic fragments derived from the ligation site.
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The results, summarized in Table 3, led to the sur-
prising ﬁnding that the diﬀerence in molecular weight
("MW) between the AO-PEGx-Fc reaction product
and the apparently “unreacted” Fc6 was consistently
approximately 238 daltons greater than expected. For
all four AO symmetroadhesins the observed "MW
corresponds to the molecular weight of the fragment
AO-PEGx-DKT. These results strongly suggest that
the smaller chain present in the one-handed hetero-
dimer is not the expected unreacted Fc6 monomer
chain but instead represents the AO-PEGx-Fc reac-
tion product which has been subsequently cleaved
within the upper hinge region (DKTHT) between the
223Thr and 224His residues (Fig. 7).
Surface plasmon resonance studies. As the
major reaction product obtained for all four AO
symmetroadhesins was the two-handed homodimer,
we investigated whether such preparations had the
HMW
Two-handed (Aβ)2-Fc
One-handed Aβ-Fc
Fc
A) Aβ-Fc
20.0 22.5 25.0 min
0.00
0.25
0.50
0.75
1.00
1.25
1.50
(x100,000)
HMW
C) Aβ-PEG24-Fc
Fc
One-handed Aβ-PEG24-Fc
Two-handed (Aβ-PEG24)2-Fc
20.0 22.5 25.0 min
0.00
0.25
0.50
0.75
1.00
1.25
1.50
(x100,000)
B) Aβ-PEG12-Fc
Fc
One-handed Aβ-PEG12-Fc
Two-handed (Aβ-PEG12)2-Fc
20.0 22.5 25.0 min
0.00
0.25
0.50
0.75
1.00
1.25
1.50
(x100,000)
HMW
D) Aβ-PEG36-Fc
Fc
One-handed Aβ-PEG36-Fc
Two-handed (Aβ-PEG36)2-Fc
20.0 22.5 25.0 min
0.00
0.25
0.50
0.75
1.00
1.25
1.50
(x100,000)
Fig. 4. SEC of the four AO-PEGx-Fc fusion proteins, as follows:
(A) AO-Fc; (B) AO-PEG12-Fc; (C) AO-PEG24-Fc; (D) AO-PEG36-
Fc. The arrows show the positions of the principal peaks corre-
spondingtotheFcdimer withtwoAO1–15 hands,oneAO1–15 hand,
and no AO1–15 hands. HMW, higher molecular weight species.
C)
B)
D)
E)
A)
(ii) Aβ-PEG12-Fc
(iii) Aβ-PEG24-Fc
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Fig. 5. SDS-PAGE analysis of SEC chromatograms of the four
AO-PEGx-Fc fusion proteins showing (A) superposition of the
four chromatograms with equal amounts of proteins injected; gel
analysis of the chromatogram fractions which are as follows: (B)
AO-Fc; (C) AO-PEG12-Fc; (D) AO-PEG24-Fc; (E) AO-PEG36-Fc.
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molecules. This analysis was carried out using a
monoclonal antibody capable of interacting with
both of the AO sequences that were incorporated into
the two-handed symmetroadhesin homodimers. The
DAEFRHDSGYEVHHQ sequence is well suited for
this purpose as it contains the principal epitope
(EFRHD) recognized by a number of monoclonal
antibodies that are reactive with human AO(1–42)
ﬁbrils including 6E10,18) PFA1 and PFA2,19) WO-
2,20) and 12A11, 10D5 and 12B4.21) Accordingly, we
characterized the binding of our AO symmetroadhe-
Table 3. AO-PEGx-Fc symmetroadhesin product sizes determined by MALDI-TOF MS analysis of SEC fractions
Reaction
MW (observed)1
"MW2 MW (theoretical)
Two-Handed One-Handed AO-PEGx-DKTHT AO-PEGx-DKT
AO-Fc 57,536 55,383 2,153 2,390 2,152
AO-PEG12-Fc 58,733 55,981 2,752 2,989 2,751
AO-PEG24-Fc 59,789 56,509 3,280 3,518 3,280
AO-PEG36-Fc 60,845 57,037 3,808 4,046 3,808
1MW for the two-handed and one-handed products in each of the four (4) reactions shown in Figs. 4A–D.
2MW diﬀerence between the two-handed and one-handed products in each reaction.
MW, molecular weight.
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Fig. 6. MS spectra of the two principal peaks of SEC chromatograms of the four AO-PEGx-Fc fusion proteins, as follows: (A) AO-Fc;
(B) AO-PEG12-Fc; (C) AO-PEG24-Fc; (D) AO-PEG36-Fc. The insets show the fractions selected from the individual chromatograms
for MS analysis.
D. J. CAPON et al. [Vol. 87, 612sins to one of these antibodies (6E10) using surface
plasmon resonance (SPR). We compared the binding
of AO peptides containing the DAEFRHDS-
GYEVHHQ sequence which were expected to bind
6E10 in a one-handed manner. Figure 8 shows the
results obtained when 6E10 was immobilized on
the surface of the SPR chip. Speciﬁc binding was
observed with all four AO symmetroadhesins
(Fig. 8A–D) and with two peptides, pen-AO and
AO-pra (Table 1), that contained the 15 amino acid
AO sequence (Fig. 8E–F). No binding was observed
with Fc6 or the DKTHT-Fc6 symmetroadhesin
(Fig. 2, lane 2) conﬁrming that binding was speciﬁc
for the AO sequence.
The binding of 6E10 by the AO symmetroadhe-
sins was qualitatively and quantitatively diﬀerent
from that of the AO peptides (Fig. 8). The kinetic
binding curves for both of the peptides gave a good ﬁt
with a 1:1 Langmuir model (Chi2 < 0.1), consistent
with one-handed binding. In contrast, the four AO
symmetroadhesins did not give a good ﬁt with the 1:1
Langmuir model (Chi2 > 10), indicating two classes
of binding sites. As summarized in Table 4, a good ﬁt
was obtained for the four AO symmetroadhesins
employing a two-exponential model (Chi2 < 1.1).
The single aﬃnity site exhibited by the pen-AO
(17nM) and AO-pra (20nM) peptides was similar to
the low aﬃnity sites observed for the AO-Fc
(140nM), AO-PEG12-Fc (93nM), AO-PEG24-Fc
(70nM) and AO-PEG36-Fc (62nM) symmetroadhe-
sins (Table 4). This low aﬃnity site was consistent
with a one-handed binding mechanism by a fraction
of the symmetroadhesin population. In addition, the
AO-Fc, AO-PEG12-Fc, AO-PEG24-Fc and AO-PEG36-
Fc symmetroadhesins all displayed a much higher
aﬃnity site that was greater by two to ﬁve orders of
magnitude over the corresponding low aﬃnity sites,
providing strong evidence for the existence of two-
handed binding of 6E10 by a signiﬁcant fraction (19–
27%) of the AO symmetroadhesins (Table 4).
Discussion
Proteins prefer to form compact globular or
ﬁbrous structures, minimizing their exposure to
Fig. 7. Schematic diagram of the structures of the two-handed and one-handed AO-PEGx-Fc fusion proteins showing a model for the
generation of a one-handed fusion protein heterodimer by cleavage of the two-handed fusion protein homodimer. The sequences of the
IgG1 hinge region are shown in boldface.
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Fig. 8. Surface plasmon resonance (SPR) analysis of binding of anti-AO mAb (6E10) binding by the four AO-PEGx-Fc fusion proteins
and two AO1–15 peptides, which are as follows: (A) AO-Fc; (B) AO-PEG12-Fc; (C) AO-PEG24-Fc; (D) AO-PEG36-Fc; (E) pen-(AO1–15),
(F) (AO1–15)-pra. The actual binding curve traces are shown in red; the binding curve ﬁts are shown in black.
Table 4. Kinetic results for Mab-6E10 binding measured by surface plasmon resonance
AO Symmetroadhesin ka2 (1/Ms) kd2 (1/s) KD2 (M) Rmax2 ka1 (1/Ms) kd1 (1/s) KD1 (M) Rmax1 Chi2
DAEFRHDSGYEVHHQ-
DKTHT-Fc6
6.119ED04 4.742E!05 7.749E!10 34.9 1.010ED04 1.414E!03 1.401E!07 91.5 0.96
DAEFRHDSGYEVHHQ-PEG12-
DKTHT-Fc6
7.858ED04 4.127E!08 5.251E!13 37.4 8.865ED03 8.290E!04 9.350E!08 155.5 0.98
DAEFRHDSGYEVHHQ-PEG24-
DKTHT-Fc6
7.965ED04 4.747E!07 5.960E!12 40 9.592ED03 6.728E!04 7.014E!08 119 1.1
DAEFRHDSGYEVHHQ-PEG36-
DKTHT-Fc6
8.347ED04 4.429E!06 5.306E!11 29.7 9.080ED03 5.695E!04 6.272E!08 119.9 0.72
AO Peptide ka1 (1/Ms) kd1 (1/s) KD1 (M) Rmax1 Chi2
pentynoyl-DAEFRHDSGYEVHHQ-
NH2
1.055ED05 2.114E!03 2.003E!08 10.4 0.039
DAEFRHDSGYEVHHQ-
propargylglycine-NH2
9.531ED04 1.601E!03 1.679E!08 12.2 0.075
D. J. CAPON et al. [Vol. 87, 614solvent. This tendency is inherent both in the
polypeptide backbone with its propensity for hydro-
gen-bonded secondary structure, and in side chain
interactions that promote tertiary folding. Thus,
previous eﬀorts to introduce “ﬂexibility” into anti-
bodies using peptides have been largely inadequate.
For example, it is common to employ combinations of
an amino acid that favors solvent interactions (e.g.,
serine) with one that breaks up helical structure (e.g.,
glycine). While this approach is useful in making
fusion proteins such as single-chain antibody frag-
ments (scFv), the resulting structures are quite com-
pact with no evidence of extendibility (for example,
see ref. 20). Furthermore, such sequences are likely
to create additional problems due to the intrinsic
immunogenicity and proteolytic susceptibility.
We pursued a novel strategy that introduces
nonprotein chains into the hinge region by chemical
semisynthesis. Our results demonstrate quantitative
yields of antibody-like molecules with nonprotein
hinges connecting two AO1–15 peptides with the Fc
dimer. These molecules form two-handed native
dimers that display high aﬃnity for an anti-AO
monoclonal antibody. Our AO-PEGx-Fc dimers with
a nonprotein hinge have an aﬃnity that is two to ﬁve
orders of magnitude greater than the cognate peptide
and appear to bind much better than the AO-Fc
dimer. A full interpretation of these results awaits
the determination of the three-dimensional structure
for the AO1–15 peptide, which contains the immuno-
dominant epitope of Alzheimer’sA O(1–42) ﬁbrils.
Although the exact conﬁguration of this epitope
(DAEFRHDS) in complex with Fab fragments has
been resolved in x-ray structures,19),21) the same
region appears disordered in 3D structures of
AO(1–42) ﬁbrils obtained by quenched hydrogen/
deuterium-exchange NMR studies.27)
Analysis by SDS-polyacrylamide gel electropho-
resis indicates that the formation of the desired AO-
PEGx-Fc fusion protein exceeds 90%. In addition, MS
analysis of the one-handed reaction products puriﬁed
by SEC indicates that they contain two reacted Fc
polypeptides (Fig. 7), one of which is full-length
while the other has been hydrolyzed at the T/HT
sequence, a major site of proteolysis (e.g., papain).9)
Thus, the overall eﬃciency of the native chemical
ligation step, excluding the subsequent cleavage, may
be much closer to 100%. The native ligation
conditions also appear to be fully compatible with
the native structure and biological activity of the
Fc dimer, while adding some of the properties of
nonprotein polymers. Our results show that the
addition of discrete oxyethylene oligomers not only
improves binding, but also appears to have a
signiﬁcant eﬀect on the hydrodynamic radius of the
Fc protein as evidenced by size-exclusion chromatog-
raphy of the AO-PEG12-Fc, AO-PEG24-Fc and AO-
PEG36-Fc molecules when compared with the AO-Fc
molecule.
MALDI-TOF MS appears to be ideally suited
for the characterization of our novel protein-
nonprotein-protein molecules. The mass contributed
by the hybrid structures can be eﬃciently charac-
terized not only in tryptic digests, but also in the
two-handed and one-handed native Fc dimers.
Ionization and desorption appear to be mediated by
the adjacent protein sequences in our protein-
nonprotein hybrid molecules, suggesting the applica-
tion of this approach to a broad range of chemically
distinct polymer chains.
In conclusion, we have described here a signiﬁ-
cant step towards our goal of the complete chemical
semisynthesis of antibodies with nonprotein hinges
that incorporate large binding domains such as the
Fab region itself or receptor extracellular domains.
Additional progress will depend upon the identiﬁca-
tion of other protein ligation reactions that can be
combined with native chemical ligation, are similarly
compatible with the native structure and function
of the cognate proteins, and which can proceed
eﬃciently at the micromolar concentrations that are
attainable with such native proteins in solution. The
antibody-like molecules we envision have enormous
potential as therapeutic candidates with improved
binding aﬃnity for their disease targets.
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